Humanized Monoclonal Antibody against SARS-CoV-2 S1RBD

SKU: 41A245

 

 

★ Download Datasheet PDF ★

 

 

Cat. No.: 41A245                                 Size:  10 or 100µg

 

Type: Genetically engineered recombinant monoclonal IgG antibody

 

  • INTRODUCTION

    The SARS-CoV-2 glycosylated spike (S) protein highly exposed on the viral surface is a major determinant for virus binding and invasion into hose cells, which is a main target for neutralization antibody. The receptor-binding domain (RBD) in SARS-CoV-2 S protein is responsible for binding to human and bat angiotensin-converting enzyme 2 (ACE2) receptors.

  • PRODUCTION

    The cDNA encoding the highly variable region of the antibody recognizing S1RBD from mammalian cells were identified by phage display library, fused with the Fc fragment of human IgG1, and expressed in Chinese Hamster Ovary (CHO) cells.

  • FORMULATION AND STORAGE

    Liquid in PBS with 0.02% azide, PH7.4. Store at -80°C. Recommend to aliquot the protein into smaller quantities. Avoid repeated freeze-thaw cycles.

  • APPLICATION/USAGE

    ELISA and other applications. Optimal concentration/dilution should be determined by the end user.

©2019 by ImmunoDiagnostics Limited.